181 related articles for article (PubMed ID: 21994427)
1. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL.
Wang Y; Snel M; Jonker JT; Hammer S; Lamb HJ; de Roos A; Meinders AE; Pijl H; Romijn JA; Smit JW; Jazet IM; Rensen PC
Diabetes Care; 2011 Dec; 34(12):2576-80. PubMed ID: 21994427
[TBL] [Abstract][Full Text] [Related]
2. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
Borggreve SE; De Vries R; Dullaart RP
Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes.
Jonker JT; Wang Y; de Haan W; Diamant M; Rijzewijk LJ; van der Meer RW; Lamb HJ; Tamsma JT; de Roos A; Romijn JA; Rensen PC; Smit JW
Diabetes Care; 2010 Jul; 33(7):1625-8. PubMed ID: 20150294
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
[TBL] [Abstract][Full Text] [Related]
5. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
De Vries R; Beusekamp BJ; Kerstens MN; Groen AK; Van Tol A; Dullaart RP
Scand J Clin Lab Invest; 2005; 65(8):729-37. PubMed ID: 16319046
[TBL] [Abstract][Full Text] [Related]
6. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure.
Martinelli AEM; Maranhão RC; Carvalho PO; Freitas FR; Silva BMO; Curiati MNC; Kalil Filho R; Pereira-Barretto AC
Lipids Health Dis; 2018 Oct; 17(1):242. PubMed ID: 30342531
[TBL] [Abstract][Full Text] [Related]
8. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
9. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
[TBL] [Abstract][Full Text] [Related]
10. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
Francone OL; Royer L; Haghpassand M
J Lipid Res; 1996 Jun; 37(6):1268-77. PubMed ID: 8808761
[TBL] [Abstract][Full Text] [Related]
11. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
[TBL] [Abstract][Full Text] [Related]
12. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L
J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
[TBL] [Abstract][Full Text] [Related]
13. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
16. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.
de Vries-van der Weij J; de Haan W; Hu L; Kuif M; Oei HL; van der Hoorn JW; Havekes LM; Princen HM; Romijn JA; Smit JW; Rensen PC
Endocrinology; 2009 May; 150(5):2368-75. PubMed ID: 19147676
[TBL] [Abstract][Full Text] [Related]
17. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment.
de Vries R; Kerstens MN; Sluiter WJ; Groen AK; van Tol A; Dullaart RP
Diabetologia; 2005 Jun; 48(6):1105-13. PubMed ID: 15875154
[TBL] [Abstract][Full Text] [Related]
18. HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men.
Talbot CPJ; Plat J; Joris PJ; Konings M; Kusters YHAM; Schalkwijk CG; Ritsch A; Mensink RP
Atherosclerosis; 2018 Jul; 274():23-28. PubMed ID: 29747087
[TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.
Le Bloc'h J; Leray V; Nazih H; Gauthier O; Serisier S; Magot T; Krempf M; Nguyen P; Ouguerram K
PLoS One; 2015; 10(9):e0136934. PubMed ID: 26366727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
